ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
避孕概念
2,592.00
-7.0786
-0.27%
涨家数:
2
跌家数:
3
平家数:
- -
市盈率:
- -
高:
2,661.42
开:
2,596.90
低:
2,514.05
收:
2,599.07
成交量:
1,136.29万
成交额:
2.95亿
市值:
416.63亿
流通市值:
408.11亿
数据加载中...
总览
新闻资讯
Veru Inc.盘中异动 急速拉升5.81%
市场透视
·
02/17
梯瓦制药与赛诺菲Duvakitug二期B阶段维持治疗数据展现溃疡性结肠炎与克罗恩病具临床意义的持久疗效
美股速递
·
02/17
曼恩凯德生物医疗宣布首例患者加入Inhale-1St儿科研究,评估Afrezza®用于新诊断1型糖尿病青少年
美股速递
·
02/09
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4584/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"避孕概念","latestPrice":2591.9956,"timestamp":1771621199999,"preClose":2599.0742,"halted":0,"volume":11362854,"delay":0,"changeRate":-0.002724,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-7.078613,"latestTime":"02-20 16:00:00 EST","open":2596.8997,"high":2661.4155,"low":2514.0496,"amount":295334513.65556,"amplitude":0.056699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.281475,"peRate":30.210268,"turnoverRate":0.007515,"increases":2,"decrements":3,"flats":0,"marketCap":41662837666,"floatMarketCap":40810627756},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2661.4155,"amplitude":0.056699,"preClose":2599.0742,"low":2514.0496,"pbRate":"5.281475","latestPrice":2591.9956,"volume":11362854,"delay":0,"open":2596.8997,"prevYearClose":2379.9924,"prevWeekClose":2576.6284,"prevMonthClose":2591.3975,"prevQuarterClose":2379.9924,"fiveDayClose":2571.6028,"twentyDayClose":2418.0854,"sixtyDayClose":1862.2355,"secType":"PLATE","market":"US","turnoverRate":0.007515,"peRate":30.210268,"marketCap":41662837666,"floatMarketCap":40810627756,"timestamp":1771621199999,"nameCN":"避孕概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":2,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612041664","title":"Veru Inc.盘中异动 急速拉升5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612041664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612041664?lang=zh_cn&edition=fundamental","pubTime":"2026-02-17 22:33","pubTimestamp":1771338815,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时33分,Veru Inc.股票出现异动,股价快速上涨5.81%。截至发稿,该股报2.42美元/股,成交量2508股,换手率0.02%,振幅5.81%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Veru Inc.公司简介:Veru Inc. 是一家专注于开发治疗心血管代谢和炎症性疾病药物的后期临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223335a4ad8782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223335a4ad8782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","VERU","BK4557","BK4584","BK4007"],"gpt_icon":0},{"id":"1173990339","title":"梯瓦制药与赛诺菲Duvakitug二期B阶段维持治疗数据展现溃疡性结肠炎与克罗恩病具临床意义的持久疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1173990339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173990339?lang=zh_cn&edition=fundamental","pubTime":"2026-02-17 19:01","pubTimestamp":1771326072,"startTime":"0","endTime":"0","summary":"梯瓦制药与法国制药巨头赛诺菲联合宣布,其共同研发的药物Duvakitug在二期B阶段临床试验的维持治疗数据中,显示出对溃疡性结肠炎和克罗恩病患者具有临床意义的持久疗效。这一积极结果标志着该疗法在治疗这两种慢性炎症性肠病方面取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","LU1983299246.USD","LU2324357040.USD","BK4584","BK4566","BK4559","BK4007","BK4585","BK4596","BK4557","BK4588"],"gpt_icon":0},{"id":"1195472595","title":"曼恩凯德生物医疗宣布首例患者加入Inhale-1St儿科研究,评估Afrezza®用于新诊断1型糖尿病青少年","url":"https://stock-news.laohu8.com/highlight/detail?id=1195472595","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195472595?lang=zh_cn&edition=fundamental","pubTime":"2026-02-09 19:10","pubTimestamp":1770635403,"startTime":"0","endTime":"0","summary":"曼恩凯德生物医疗宣布,其Inhale-1St儿科研究项目已完成首例患者入组。该研究旨在评估吸入式胰岛素产品Afrezza®在新确诊1型糖尿病青少年群体中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}